Galapagos NV (GLPG): Price and Financial Metrics

Galapagos NV (GLPG): $57.11

1.31 (+2.35%)

POWR Rating

Component Grades













Add GLPG to Watchlist
Sign Up

Industry: Biotech



in industry


  • Value is the dimension where GLPG ranks best; there it ranks ahead of 63.28% of US stocks.
  • The strongest trend for GLPG is in Value, which has been heading down over the past 179 days.
  • GLPG's current lowest rank is in the Momentum metric (where it is better than 8.18% of US stocks).

GLPG Stock Summary

  • The ratio of debt to operating expenses for Galapagos Nv is higher than it is for about merely 8.98% of US stocks.
  • Over the past twelve months, GLPG has reported earnings growth of -168.01%, putting it ahead of merely 11.46% of US stocks in our set.
  • As for revenue growth, note that GLPG's revenue has grown -49.04% over the past 12 months; that beats the revenue growth of only 3.31% of US companies in our set.
  • Stocks that are quantitatively similar to GLPG, based on their financial statements, market capitalization, and price volatility, are HIMX, IMMP, VALN, HCM, and VNE.
  • Visit GLPG's SEC page to see the company's official filings. To visit the company's web site, go to

GLPG Stock Price Chart Interactive Chart >

Price chart for GLPG

GLPG Price/Volume Stats

Current price $57.11 52-week high $81.12
Prev. close $55.80 52-week low $46.41
Day low $55.76 Volume 171,300
Day high $57.11 Avg. volume 365,525
50-day MA $61.71 Dividend yield N/A
200-day MA $57.61 Market Cap 3.75B

Galapagos NV (GLPG) Company Bio

Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines in areas such as cystic fibrosis, inflammation, and other indications. The company was founded in 1999 and is Mechelen, Belgium.

GLPG Latest News Stream

Event/Time News Detail
Loading, please wait...

GLPG Latest Social Stream

Loading social stream, please wait...

View Full GLPG Social Stream

Latest GLPG News From Around the Web

Below are the latest news stories about Galapagos Nv that investors may wish to consider to help them evaluate GLPG as an investment opportunity.

Galapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2021 Results - Earnings Call Transcript

Galapagos NV (GLPG) Q4 2021 Earnings Conference Call February 25, 2022 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer Walid Abi-Saab - Chief Medical Officer Michele Manto - Chief Commercial Officer...

SA Transcripts on Seeking Alpha | February 25, 2022

Galapagos GAAP EPS of -€1.58, revenue of €484.85M

Galapagos press release (GLPG): FY GAAP EPS of -€1.58.Revenue of €484.85M (+1.4% Y/Y).Cash and current financial investments of €4.7 billion on 31 December 2021Operational cash burn…

Seeking Alpha | February 24, 2022

Galapagos 2021 results set stage for future growth

Key 2021 and post period events: Appointment of Dr. Paul Stoffels1 as new CEO, effective 1 April 2022, following planned retirement of CEO and co-founder Onno van de StolpeJyseleca sales booked by Galapagos in Europe were €14.8 million out of a total in-market performance of €25.7 millionJyseleca (filgotinib) approved for ulcerative colitis (UC) in Europe and Great Britain, reimbursement for rheumatoid arthritis (RA) secured in 14 countriesPatient enrollment completed in the DIVERSITY Phase 3 pr

Yahoo | February 24, 2022

Galapagos: A History Of Disruptive Failures

I used to cover Galapagos (GLPG) quite extensively a few years ago, even going so far as to interview its then CEO, Mr. Onno van de Stolpe. I generally avoid interviews because I prefer to stay neutral. So anyway, I last covered Galapagos in March last year, a few months...

Avisol Capital Partners on Seeking Alpha | February 22, 2022

Galapagos receives transparency notification from EcoR1 Capital

Mechelen, Belgium; 03 February 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a new transparency notification from EcoR1 Capital, LLC. Pursuant to Belgian transparency legislation1, Galapagos received a transparency notification on 2 February 2022 from EcoR1 Capital LLC, who notified that it holds 3,407,246 of Galapagos’ voting rights, consisting of 211,622 ordinary shares and 3,195,624 American Depository Receipts. EcoR1 Capital LLC, controlled by Mr. N

Yahoo | February 3, 2022

Read More 'GLPG' Stories Here

GLPG Price Returns

1-mo -3.37%
3-mo -13.13%
6-mo 18.39%
1-year -24.99%
3-year -50.30%
5-year -31.02%
YTD 3.59%
2021 -44.30%
2020 -52.14%
2019 125.45%
2018 -2.15%
2017 46.07%

Continue Researching GLPG

Want to see what other sources are saying about Galapagos Nv's financials and stock price? Try the links below:

Galapagos Nv (GLPG) Stock Price | Nasdaq
Galapagos Nv (GLPG) Stock Quote, History and News - Yahoo Finance
Galapagos Nv (GLPG) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7211 seconds.